Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

about

Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.

P2860

Q40515140-1AA3471D-6E5B-42A0-9F57-95F9F6226065 Q47098888-A20D9278-1016-4D78-8D64-BDE541138705

P2860

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

Item

http://www.wikidata.org/entity/Q39816665

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@en

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@nl

type

Item

label

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@en

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@nl

prefLabel

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@en

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@nl

P1476

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

@en

P2093

Alan Howard

http://www.w3.org/2001/XMLSchema#string

Alan Mendizabal

http://www.w3.org/2001/XMLSchema#string

Blood and Marrow Transplant Clinical Trials Network

http://www.w3.org/2001/XMLSchema#string

Charles A Peloquin

http://www.w3.org/2001/XMLSchema#string

Dennis L Confer

http://www.w3.org/2001/XMLSchema#string

Joanne Goodwin

http://www.w3.org/2001/XMLSchema#string

Joanne Kurtzberg

http://www.w3.org/2001/XMLSchema#string

John R Wingard

http://www.w3.org/2001/XMLSchema#string

Michael N Neely

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole therapeutic drug monitoring.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.

Achieving target voriconazole concentrations more accurately in children and adolescents.

P304

2234-2240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW127

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Hope

Juergen Bulitta

Lindsey R Baden

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27121401

http://www.w3.org/2001/XMLSchema#string

P932

4954923

http://www.w3.org/2001/XMLSchema#string

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

about

P2860

P2860

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932